Asymmetric silicon phthalocyanine based nanoparticle with spatiotemporally targeting of mitochondria for synergistic apoptosis-ferroptosis antitumor treatment
This study offers compelling evidence that FECTPN can effectively induce ferroptosis and reinforces the paradigm of a synergistic apoptosis-ferroptosis pathway in cancer therapy, proposing a novel route for augmented antitumor treatments.PMID:38608462 | DOI:10.1016/j.colsurfb.2024.113890
Source: Colloids and Surfaces - Category: Biotechnology Authors: Yan Huang Guowei Liu Fangmei Zheng Jianling Chen Youyu Lin Junwei Wang Yide Huang Yiru Peng Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Chemistry | Iron | Mitochondria | Nanotechnology | Study